{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:31:20Z","timestamp":1790803880895,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.diagmicrobio.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T08:01:56Z","timestamp":1454486516000},"page":"177-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex"],"prefix":"10.1016","volume":"85","author":[{"given":"Zenda L.","family":"Berrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Yean Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duylinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela F.","family":"Schecter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Elmaraachli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-0711-4-9","article-title":"Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency","volume":"4","author":"Anthony","year":"2005","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tube.2010.02.001","article-title":"Rifamycins-Obstacles and opportunities","volume":"90","author":"Aristoff","year":"2010","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2016.01.019_bb0185","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.04058-14","article-title":"Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"59","author":"Bernard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/35.2.345","article-title":"Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis","volume":"35","author":"Bodmer","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1469-0691.2004.00917.x","article-title":"In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations","volume":"10","author":"Cavusoglu","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0070","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1128\/JCM.00652-12","article-title":"Molecular detection of rifabutin-susceptible Mycobacterium tuberculosis","volume":"50","author":"Chen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0130","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard- Second Edition","author":"Clinical Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005159.pub2","article-title":"Rifabutin for treating pulmonary tuberculosis","author":"Davies","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0030","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.00149-10","article-title":"Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis","volume":"54","author":"Garc\u00eda","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/25.3.490","article-title":"The serum rifabutin concentrations in a patient successfully treated for multi-resistant Mycobacterium tuberculosis infection","volume":"25","author":"Gillespie","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0110","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/JCM.02149-09","article-title":"Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens","volume":"48","author":"Halse","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/ajrccm\/137.3.719","article-title":"Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis","volume":"137","author":"Heifets","year":"1998","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1745-6215-15-434","article-title":"The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): Design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis","volume":"15","author":"Hillery","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0025","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5588\/ijtld.11.0068","article-title":"Experience with rifabutin replacing rifampin in the treatment of tuberculosis","volume":"15","author":"Horne","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2016.01.019_bb0075","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/JCM.00691-14","article-title":"Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis","volume":"52","author":"Jamieson","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first-and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cll.2014.02.005","article-title":"Molecular Diagnosis of Tuberculosis and Drug Resistance","volume":"34","author":"Lin","year":"2014","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JCM.01821-13","article-title":"Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens","volume":"52","author":"Lin","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/36.2.355","article-title":"In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli","volume":"36","author":"Luna-Herrera","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0145","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0190","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JCM.02741-12","article-title":"Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations","volume":"51","author":"Rigouts","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0150","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","article-title":"Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials","volume":"44","author":"R\u00fcsch-Gerdes","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"S2","key":"10.1016\/j.diagmicrobio.2016.01.019_bb0170","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/infdis\/jiu816","article-title":"Integration of published information into a resistance-associated mutation database for Mycobaterium tuberculosis","volume":"211","author":"Salamon","year":"2015","journal-title":"J Inf Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2016.01.019_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0175","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/jac\/dkt150","article-title":"Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?","volume":"68","author":"Sch\u00f6n","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/003130299105089","article-title":"Mutations in RpoB Gene and Rifabutin Susceptibility of Multidrug-Resistant Mycobacterium Tuberculosis Strains Isolated in Australia","volume":"31","author":"Sintchenko","year":"1999","journal-title":"Pathology"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059414","article-title":"The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks","volume":"8","author":"Sirgel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/JCM.05092-11","article-title":"The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin\/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China","volume":"50","author":"Tan","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0040","first-page":"164","article-title":"Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains","volume":"6","author":"Uzun","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"van den Boogaard","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0195","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","article-title":"Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results","volume":"47","author":"Van Deun","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0200","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"Van Deun","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0090","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1128\/JCM.00652-10","article-title":"Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates","volume":"48","author":"Van Ingen","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0050","doi-asserted-by":"crossref","first-page":"990","DOI":"10.5588\/ijtld.10.0127","article-title":"Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge","volume":"15","author":"Van Ingen","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0095","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.42.7.1853","article-title":"Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis","volume":"42","author":"Williams","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0155","series-title":"Treatment of Tuberculosis Guidelines","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/42.5.621","article-title":"Relationship between ntimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis","volume":"42","author":"Yang","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10156-010-0057-5","article-title":"Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay","volume":"16","author":"Yoshida","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.01.019_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2004.10.001","article-title":"Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis","volume":"51","author":"Zhao","year":"2005","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T21:44:48Z","timestamp":1600119888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0732889316300013"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.01.019","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}